Phathom Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $6.1M, a 15.9% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $42.4M, a 58.5% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45M, a 86.6% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.1M, a 43.5% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.8M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $45M +$20.9M +86.6% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-06-14
2022 $24.1M +$7.32M +43.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-06-14
2021 $16.8M +$11M +188% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $5.84M +$5.43M +1338% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $406K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.